TDC
OPTN

Thompson Davis & Co’s OptiNose OPTN Stock Holding History

Thompson Davis & Co’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$2K Sell
8
-242
-97% -$69K ﹤0.01% 670
2018
Q2 		$105K Buy
+250
New +$84.3K 0.25% 94

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thompson Davis & Co's OPTN Position: Q3 2018 in Review

Thompson Davis & Co reduced its OptiNose (OPTN) stake by 97% in Q3 2018, selling an estimated $69K and leaving 8 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Thompson Davis & Co first reported a position in OPTN in Q2 2018 and has held it in 2 quarters since. The position peaked at $105K in Q2 2018. 64 funds tracked by Wall St. Rank hold OPTN as of Q3 2018.

  • Thompson Davis & Co held 8 shares of OptiNose worth $2K as of Q3 2018.
  • Thompson Davis & Co sold 242 OptiNose shares in Q3 2018, an estimated $69K.
  • OptiNose made up ﹤0.01% of Thompson Davis & Co's portfolio in Q3 2018, its #670 holding.
  • Thompson Davis & Co first reported a position in OptiNose in Q2 2018 and has held it in 2 quarters since.
  • Thompson Davis & Co's OptiNose position peaked at $105K in Q2 2018.
  • 64 funds tracked by Wall St. Rank held OptiNose as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.